Oral Mucositis Newswire

Main Navigation

ORAL MUCOSITIS NEWSWIRE: Category Archive for Wall Street Journalist

At Least 8 Biotech Firms Vie for a Treatment/Prevention for Oral Mucositis

Posted by Oral Mucosistis Newsroom at 10/2/2009 11:48 AM | Add Comment

BusinessWeek Columnist Says Maker of Treatment for Oral Mucositis Could Be Takeover Target

Posted by Oral Mucosistis Newsroom at 10/1/2009 5:11 PM

Back to Main Page

Quick Search

Monthly Archives

Category Archives

Recent Entries

  1. At Least 8 Biotech Firms Vie for a Treatment/Prevention for Oral Mucositis
    Friday, October 02, 2009
  2. BusinessWeek Columnist Says Maker of Treatment for Oral Mucositis Could Be Takeover Target
    Thursday, October 01, 2009
  3. Number of Oral Mucositis Cases May Rise Due To Newer Cancer Treatments - Expert
    Monday, September 21, 2009
  4. Oral Spray Proves Effective in Treating Oral Mucositis in Phase II Study
    Monday, September 21, 2009
  5. Access Pharmaceuticals Takes Important Step To Make Its Oral Mucositis Treatment Available in the United States
    Friday, September 11, 2009
  6. Two Makers of Oral Mucositis Treatments Plan to Address Investors This Week
    Tuesday, September 08, 2009
  7. In all probability, Senator Kennedy also suffered from Oral Mucositis
    Saturday, August 29, 2009
  8. Oral Mucositis is a Common Side Effect of Chemotherapy and Radiation Treatments
    Monday, August 24, 2009
  9. The Story of Two Cancer Patients Who Developed Oral Mucositis
    Monday, August 24, 2009
  10. Oral Mucositis Newswire Glossary
    Sunday, August 23, 2009

Recent Comments

Subscribe


Oral Mucositis Newswire is written and published by TJFR Consulting Company, which provides strategic media relations consulting and related editorial services.  Access Pharmaceuticals is one of TJFR’s clients in the health care field.


For additional information on Oral Mucositis Newswire (www.oralmucositisnewswire) or TJFR Consulting, please contact Dean Rotbart, chairman and executive editor, at 310-492-5858. ©2009 TJFR Group, Inc.  All rights reserved.  No electronic or print reprints without written permission.